Could research on "peacekeeper" T-cells offer a new path to autoimmune treatment?

Autoimmune diseases occur when the immune system mistakenly attacks healthy cells and tissue. T-cells—a type of white blood cell—are largely responsible for defending the body against viruses and bacteria. However, when T-cells have trouble distinguishing between foreign peptide antigens and self-peptides (pieces of protein from our own body), this can lead to autoimmunity. 

New research from the University of Chicago studied a group of T-cells called Treg cells (short for regulatory T-cells), which essentially "keep the peace" within the body by preventing helper T-cells from attacking the body's own tissue. When self-peptides are presented, the peacekeeper Treg cells are trained to spot them and intervene to stop helper T-cells from being triggered and attacking those peptides.

In a study on mice, researchers removed Treg cells that specialize in recognizing a particular self-peptide from the prostate. In healthy mice, this change did not trigger an autoimmune response. However, in mice that were infected with a bacterium that expressed a peptide similar to the prostate self-peptide (or displayed a protein fragment that resembled it), helper T-cells became activated and attacked both the bacterium and the prostate, triggering autoimmunity. Without the Treg cells to control self-reactive responses and prevent "friendly fire," the helper T-cells attacked the mice's prostate cells.

From the study, researchers concluded that for each type of helper T-cell that is capable of triggering autoimmunity through a specific protein, there is a "doppelganger" or corresponding set of Treg cells that can suppress or regulate that response to prevent attacks on the self-peptides. Where conventional autoimmune treatment has focused on suppressing the immune system and indiscriminately purging helper and Treg T-cells, this research offers a more efficient path forward. Dr. Pete Savage proposes that "instead of having to delete all helper T-cells reactive to self-antigens, you simply generate enough of these Treg peacekeeper cells instead." The idea is to identify the specific helper T-cells involved in an autoimmune response and then expand or introduce their matching Treg cells to restore immune balance and prevent self-attacking.

A treatment based on these findings could be a game-changer for patients. It not only offers an alternate path for drug development, but also offers a more targeted solution that could lead to safer long-term outcomes. While the research is still in its early stages, its potential to transform autoimmune disease treatment is promising and exciting.

To support the Autoimmune Registry, please share our information with others who have autoimmune diseases. Donations are also greatly appreciated!